Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer.

Dorbin D, Herrera J, Davidson R, Chandrashekar NK, Scheuber G, Jayakrishnan P, Rajesh C, Johnson G, Yuan J, Sochor MA, Langenheim JF, Aldakkak M, Messerly C, Wittmann J, Szabo A, Sayahpour FA, Atallah NL, Peterson FC, Volkman BF, Ali M, Ke E, Evans DB, Tsai S, Lytle NK, Seo YD, Kurzrock R, Hobbs GA, Kamgar M, McFall T

Open source

DOI: 10.1158/0008-5472.can-26-1181
Published: 2026 Aug 27
Container: Cancer research
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/0008-5472.can-26-1181,
  title = {Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer.},
  author = {Dorbin D and Herrera J and Davidson R and Chandrashekar NK and Scheuber G and Jayakrishnan P and Rajesh C and Johnson G and Yuan J and Sochor MA and Langenheim JF and Aldakkak M and Messerly C and Wittmann J and Szabo A and Sayahpour FA and Atallah NL and Peterson FC and Volkman BF and Ali M and Ke E and Evans DB and Tsai S and Lytle NK and Seo YD and Kurzrock R and Hobbs GA and Kamgar M and McFall T},
  year = {2026},
  journal = {Cancer research},
  doi = {10.1158/0008-5472.can-26-1181},
  url = {https://doi.org/10.1158/0008-5472.can-26-1181}
}

RIS

TY  - JOUR
TI  - Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer.
AU  - Dorbin D
AU  - Herrera J
AU  - Davidson R
AU  - Chandrashekar NK
AU  - Scheuber G
AU  - Jayakrishnan P
AU  - Rajesh C
AU  - Johnson G
AU  - Yuan J
AU  - Sochor MA
AU  - Langenheim JF
AU  - Aldakkak M
AU  - Messerly C
AU  - Wittmann J
AU  - Szabo A
AU  - Sayahpour FA
AU  - Atallah NL
AU  - Peterson FC
AU  - Volkman BF
AU  - Ali M
AU  - Ke E
AU  - Evans DB
AU  - Tsai S
AU  - Lytle NK
AU  - Seo YD
AU  - Kurzrock R
AU  - Hobbs GA
AU  - Kamgar M
AU  - McFall T
PY  - 2026
JO  - Cancer research
DO  - 10.1158/0008-5472.can-26-1181
UR  - https://doi.org/10.1158/0008-5472.can-26-1181
ER  -

APA

D, D., J, H., R, D., NK, C., G, S., P, J., C, R., G, J., J, Y., MA, S., JF, L., M, A., C, M., J, W., A, S., FA, S., NL, A., FC, P., BF, V., M, A., E, K., DB, E., S, T., NK, L., YD, S., R, K., GA, H., M, K., & T, M. (2026). Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer.. Cancer research. https://doi.org/10.1158/0008-5472.can-26-1181

Source records

pubmed · retrieved 2026-09-27T16:49:07.567Z